FY2025 · ended Dec 31, 2025 · Revenue $6.84M, +4.7% YoY · Filed Jun 2, 2026
INVO Fertility, Inc. (IVF) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $6.8 million and a net loss of $23.3 million. Free cash flow was -$7.1 million. As of Jun 30, 2026 it held $3.7 million in cash and investments and $3.9 million in total debt.
Revenue (TTM)
$7.53M
+13.8% vs year-ago TTM
Net income (TTM)
$-6.95M
+73.7% vs year-ago TTM
Operating cash flow (TTM)
$-4.77M
+26.9% vs year-ago TTM
Free cash flow (TTM)
$-4.81M
+27.4% vs year-ago TTM
EPS (TTM)
$-6.69
-100.9% vs year-ago TTM
Dividend per share
None
Shares outstanding
1.79M
+0.0% vs prior year
Net cash
$-188,753
as of Jun 30, 2026
Operating margin
-78.7%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- IVF (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Sarasota, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1417926
- Former names
- NAYA Biosciences, Inc. (until Apr 14, 2025); INVO Bioscience, Inc. (until Oct 15, 2024); EMY'S SALSA AJI DISTRIBUTION COMPANY, INC. (until Jan 5, 2009)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $6.8M | $6.5M | $3.0M | $822,196 | $4.2M |
| Operating income | -$7.2M | -$6.6M | -$6.8M | -$10.6M | -$5.2M |
| Net income | -$23.3M | -$9.3M | -$8.0M | -$10.9M | -$6.7M |
| Diluted EPS | -$214.64 | -$3,782.65 | -$67.37 | -$17.97 | -$0.63 |
| Operating cash flow | -$7.0M | -$3.0M | -$4.8M | -$6.6M | -$6.0M |
| Free cash flow | -$7.1M | -$3.2M | -$5.2M | -$6.6M | -$6.4M |
| Total assets | $20.2M | $46.1M | $18.5M | $3.7M | $10.0M |
| Total liabilities | $13.0M | $26.0M | $17.6M | $4.7M | $2.7M |
| Stockholders' equity | $7.2M | $12.6M | $892,825 | -$977,612 | — |
| Cash and investments | $2.1M | $619,520 | $232,424 | $90,135 | $5.7M |
| Total debt | $3.4M | $1.6M | $3.5M | $1.5M | $2.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Nov 4, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 28, 2026 | Aug 28, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 17, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results
|
Jul 24, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 25, 2026 | Jun 23, 2026 |
All 596 INVO Fertility, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.